Search research articles
Contact Us
Filters
Showing results (221-230 of 292) with videos related to
Page
of 30
Sort By:
Cancer Medicine
|
December 27, 2019
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
Mark Yarchoan, Chiung-Yu Huang, Qingfeng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2011
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction
Dung T Le, Dirk G Brockstedt, Ran Nir-Paz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2020
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer
Takahiro Tsujikawa, Todd Crocenzi, Jennifer N Durham, et al.
Cell Reports
|
April 6, 2017
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa, Sushil Kumar, Rohan N Borkar, et al.
Nature
|
June 1, 2022
Stromal changes in the aged lung induce an emergence from melanoma dormancy
Mitchell E Fane, Yash Chhabra, Gretchen M Alicea, et al.
Cell Reports
|
August 25, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkers
Rossin Erbe, Zheyu Wang, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2019
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)
Dung T Le, Vincent J Picozzi, Andrew H Ko, et al.
Cancer Immunology Research
|
March 27, 2025
Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines
Mari Nakazawa, Soren Charmsaz, Elsa Hallab, et al.
The Journal of Clinical Investigation
|
July 20, 2021
Systemic inhibition of PTPN22 augments anticancer immunity
Won Jin Ho, Sarah Croessmann, Jianping Lin, et al.
Cancer Discovery
|
April 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception
Monte M Winslow, Mohamed A Ahmed, Christine D Berg, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 292) with videos related to
Sort By:
Page
of 30
Cancer Medicine
|
December 27, 2019
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
Mark Yarchoan, Chiung-Yu Huang, Qingfeng Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2011
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction
Dung T Le, Dirk G Brockstedt, Ran Nir-Paz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2020
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer
Takahiro Tsujikawa, Todd Crocenzi, Jennifer N Durham, et al.
Cell Reports
|
April 6, 2017
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa, Sushil Kumar, Rohan N Borkar, et al.
Nature
|
June 1, 2022
Stromal changes in the aged lung induce an emergence from melanoma dormancy
Mitchell E Fane, Yash Chhabra, Gretchen M Alicea, et al.
Cell Reports
|
August 25, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkers
Rossin Erbe, Zheyu Wang, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2019
Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)
Dung T Le, Vincent J Picozzi, Andrew H Ko, et al.
Cancer Immunology Research
|
March 27, 2025
Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines
Mari Nakazawa, Soren Charmsaz, Elsa Hallab, et al.
The Journal of Clinical Investigation
|
July 20, 2021
Systemic inhibition of PTPN22 augments anticancer immunity
Won Jin Ho, Sarah Croessmann, Jianping Lin, et al.
Cancer Discovery
|
April 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception
Monte M Winslow, Mohamed A Ahmed, Christine D Berg, et al.
Page
of 30